REVIEW ON LOSARTAN INDUCED HYPONATREMIA
Abstract
Hyponatremia is a frequently encountered electrolyte imbalance associated with significant morbidity and mortality. While diuretics, selective serotonin reuptake inhibitors (SSRIs), and anticonvulsants are well-recognized causes, angiotensin II receptor blockers (ARBs), particularly losartan, have also been implicated in rare cases. This review explores the potential mechanisms, clinical evidence, risk factors, diagnostic considerations, and management strategies related to losartan-induced hyponatremia. Awareness of this uncommon yet clinically significant adverse effect is essential for early recognition and prevention of complications.
References
2. Mansukhbhai, H. J., Gupta, S., Sood, V. S., & Malhotra, S. D. (2019). Hyponatremia following losartan therapy in a patient with cerebrovascular attack: A case report. National Journal of Integrated Research in Medicine, 10(4), 83–85.
3. Kinoshita, H., Kobayashi, K., Yaguramaki, T., Yasuda, M., &Fujiki, K. (2011). Losartan potassium/hydrochlorothiazide and hyponatremia: Case series of 40 patients. Human & Experimental Toxicology, 30(9), 1409–1414.
4. Bhuvaneshwari, S., et al. (2018). Study on hyponatremia induced by ACEI and ARB. Journal of Clinical and Diagnostic Research, 12(7), FC01–FC03.
5. Dr.Oracle AI. (2025, July 24). Can Losartan cause hyponatremia?
6. Sreelekshmi, V., Rajeev, A., Divyaja, M., Thattaruparambil, S., & Krishna Kumar, M. (2021). Combinational drug therapy induced severe hyponatremia in a hypertensive patient. Indian Journal of Pharmacy Practice, 14(4), 308–310
All the articles are published in AJMNS are under Creative Commons License. Any further distribution or use of content published under CC BY-NC 4.0 must maintain attribution to the author(s) and the published article’s title, journal citation Creative Commons Attribution-NonCommercial 4.0 Unported License.
subrahmanyamsatupati@gmail.com
